Probing the “fingers” domain binding pocket of Hepatitis C virus NS5B RdRp and D559G resistance mutation via molecular docking, molecular dynamics simulation and binding free energy calculations

References

• Ahmed-Belkacem, A., Guichou, J. F., Brillet, R., Ahnou, N., Hernandez, E., Pallier, C., & Pawlotsky, J. M. (2014). Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: A new mechanism for antiviral intervention. Nucleic Acids Research, 42(14), 9399–9409. doi:10.1093/nar/gku632
   PubMed Web of Science ®Google Scholar
• Arputharaj, D. S., Hathwar, V. R., Guru Row, T. N., & Kumaradhas, P. (2012). Topological electron density analysis and electrostatic properties of aspirin: An experimental and theoretical study. Crystal Growth & Design, 12(9), 4357–4366. doi:10.1021/cg300269n
   Web of Science ®Google Scholar
• Bakan, A., Meireles, L. M., & Bahar, I. (2011). ProDy: Protein dynamics inferred from theory and experiments. Bioinformatics, 27(11), 1575–1577. doi:10.1093/bioinformatics/btr168
   PubMed Web of Science ®Google Scholar
• Bhandare, V. V., & Ramaswamy, A. (2018). The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study. Journal of Biomolecular Structure and Dynamics, 36(4), 1075–1093. doi:10.1080/07391102.2017.1310670
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. doi:10.1063/1.448118
   Web of Science ®Google Scholar
• Bressanelli, S., Tomei, L., Roussel, A., Incitti, I., Vitale, R. L., Mathieu, M., … Rey, F. A. (1999). Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proceedings of the National Academy of Sciences, 96(23), 13034–13039. doi:10.1073/pnas.96.23.13034
   PubMed Web of Science ®Google Scholar
• Case, D. A., Babin, V., Berryman, J. T., Betz, R. M., Cai, Q., Cerutti, D. S., … Kollman, P. A. (2014). AMBER 14. San Francisco: University of California.
   Google Scholar
• Cummings, M. D., Lin, T.-I., Hu, L., Tahri, A., McGowan, D., Amssoms, K., … Vendeville, S. (2012). Structure-based macrocyclization yields hepatitis C virus NS5B inhibitors with improved binding affinities and pharmacokinetic properties. Angewandte Chemie International Edition, 51(19), 4637–4640. doi:10.1002/anie.201200110
   PubMed Web of Science ®Google Scholar
• De Francesco, R., & Migliaccio, G. (2005). Challenges and successes in developing new therapies for hepatitis C. Nature, 436(7053), 953–960. doi:10.1038/nature04080
   PubMed Web of Science ®Google Scholar
• Delano, W. L. (2002). PyMol molecular graphics system. SanCarlos, CA: Delano Scientific.
   Google Scholar
• Dror, R. O., Dirks, R. M., Grossman, J. P., Xu, H., & Shaw, D. E. (2012). Biomolecular simulation: A computational microscope for molecular biology. Annual Review of Biophysics, 41(1), 429–452. doi:10.1146/annurev-biophys-042910-155245
   PubMed Web of Science ®Google Scholar
• Durrant, J. D., & McCammon, J. A. (2011). Molecular dynamics simulations and drug discovery. BMC Biology, 9(1), 71. doi:10.1186/1741-7007-9-71
   PubMed Web of Science ®Google Scholar
• Eisenberg, D., Lüthy, R., & Bowie, J. U. (1997). VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods in Enzymology, 277, 396–404. doi:10.1016/S0076-6879(97)77022-8
   Google Scholar
• Eltahla, A., Luciani, F., White, P., Lloyd, A., & Bull, R. (2015). Inhibitors of the hepatitis C virus polymerase; mode of action and resistance. Viruses, 7(10), 5206–5224. doi:10.3390/v7102868
   PubMed Web of Science ®Google Scholar
• Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. doi:10.1063/1.470117
   Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., …., Pople, J. A. (2005). Gaussian 03, revision D.1. Wallingford, CT: Gaussian, Inc. Retrieved from http://gaussian.com/g03citation/
   Google Scholar
• Gentles, R. G., Ding, M., Bender, J. A., Bergstrom, C. P., Grant-Young, K., Hewawasam, P., … Kadow, J. F. (2014). Discovery and preclinical characterization of the cyclopropylindolobenzazepine BMS-791325, a potent allosteric inhibitor of the hepatitis C virus NS5B polymerase. Journal of Medicinal Chemistry, 57(5), 1855–1879. doi:10.1021/jm4016894
   PubMed Web of Science ®Google Scholar
• Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., & Razavi, H. (2014). Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology, 61(1), S45–S57. doi:10.1016/j.jhep.2014.07.027
   PubMed Web of Science ®Google Scholar
• Harrach, M. F., & Drossel, B. (2014). Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. The Journal of Chemical Physics, 140(17), 174501. doi:10.1063/1.4872239
   PubMed Web of Science ®Google Scholar
• Heim, M. H. (2013). 25 years of interferon-based treatment of chronic hepatitis C: An epoch coming to an end. Nature Reviews Immunology, 13(7), 535–542. doi:10.1038/nri3463
   PubMed Web of Science ®Google Scholar
• Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006). Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics, 65(3), 712–725. doi:10.1002/prot.21123
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. doi:10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins: Structure, Function, and Bioinformatics, 55(2), 351–367. doi:10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jiang, M., Zhang, E. Z., Ardzinski, A., Tigges, A., Davis, A., Sullivan, J. C., … Kieffer, T. L. (2014). Genotypic and phenotypic analyses of hepatitis C virus variants observed in clinical studies of VX-222, a nonnucleoside NS5B polymerase inhibitor. Antimicrobial Agents and Chemotherapy, 58(9), 5456–5465. doi:10.1128/AAC.03052-14
   PubMed Web of Science ®Google Scholar
• Jiao, P., Xue, W., Shen, Y., Jin, N., & Liu, H. (2014). Understanding the drug resistance mechanism of hepatitis C virus NS5B to PF-00868554 due to mutations of the 423 site: A computational study. Molecular Biosystems, 10(4), 767. doi:10.1039/c3mb70498j
   PubMedGoogle Scholar
• Kalaiarasi, C., Pavan, M. S., & Kumaradhas, P. (2016). Topological characterization of electron density, electrostatic potential and intermolecular interactions of 2-nitroimidazole: An experimental and theoretical study. Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials, 72(5), 775–786. doi:10.1107/S2052520616010581
   PubMedGoogle Scholar
• Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., … Cheatham, T. E. (2000). Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models. Accounts of Chemical Research, 33(12), 889. doi:10.1021/AR000033J
   PubMed Web of Science ®Google Scholar
• Labanowski, J. K., & Andzelm, J. W. (Eds.). (1991). Density functional methods in chemistry. New York, NY: Springer New York. doi:10.1007/978-1-4612-3136-3
   Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. doi:10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Larrey, D., Lohse, A. W., Trepo, C., Bronowicki, J.-P., Arastéh, K., Bourlière, M., … Kukolj, G. (2013). Antiviral effect, safety, and pharmacokinetics of five-day oral administration of deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C. Antimicrobial Agents and Chemotherapy, 57(10), 4727–4735. doi:10.1128/AAC.00565-13
   PubMed Web of Science ®Google Scholar
• Lauer, G. M., & Walker, B. D. (2001). Hepatitis C virus infection. New England Journal of Medicine, 345(1), 41–52. doi:10.1056/NEJM200107053450107
   PubMed Web of Science ®Google Scholar
• Lemm, J. A., Liu, M., Gentles, R. G., Ding, M., Voss, S., Pelosi, L. A., … Gao, M. (2014). Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C virus NS5B polymerase. Antimicrobial Agents and Chemotherapy, 58(6), 3485–3495. doi:10.1128/AAC.02495-13
   PubMed Web of Science ®Google Scholar
• Li, L., Li, Y., Zhang, L., & Hou, T. (2012). Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase. Journal of Chemical Information and Modeling, 52(10), 2715–2729. doi:10.1021/ci300375k
   PubMed Web of Science ®Google Scholar
• Li, H., Tatlock, J., Linton, A., Gonzalez, J., Jewell, T., Patel, L., … Lewis, C. (2009). Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor. Journal of Medicinal Chemistry, 52(5), 1255–1258. doi:10.1021/jm8014537
   PubMed Web of Science ®Google Scholar
• Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., … Richardson, D. C. (2003). Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450. doi:10.1002/prot.10286
   PubMed Web of Science ®Google Scholar
• MacArthur, M. W., Laskowski, R. A., & Thornton, J. M. (1994). Knowledge-based validation of protein structure coordinates derived by X-ray crystallography and NMR spectroscopy. Current Opinion in Structural Biology, 4(5), 731–737. doi:10.1016/S0959-440X(94)90172-4
   Web of Science ®Google Scholar
• Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K., & Simmerling, C. (2015). ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. doi:10.1021/acs.jctc.5b00255
   PubMed Web of Science ®Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105, 9954–9960. doi:10.1021/jp003020w
   Web of Science ®Google Scholar
• Meeprasert, A., Hannongbua, S., & Rungrotmongkol, T. (2014). Key binding and susceptibility of NS3/4A serine protease inhibitors against hepatitis C virus. Journal of Chemical Information and Modeling, 54(4), 1208–1217. doi:10.1021/ci400605a
   PubMed Web of Science ®Google Scholar
• Membreno, F. E., & Lawitz, E. J. (2011). The HCV NS5B nucleoside and non-nucleoside inhibitors. Clinics in Liver Disease, 15(3), 611–626. doi:10.1016/j.cld.2011.05.003
   PubMed Web of Science ®Google Scholar
• Parr, R. G., & Yang, W. (1989). Density functional theory of atoms and molecules. New York, NY: Oxford.
   Google Scholar
• Peddi, S. R., Sivan, S. K., & Manga, V. (2018). Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors. Journal of Biomolecular Structure and Dynamics, 36(2), 486–503. doi:10.1080/07391102.2017.1281762
   PubMed Web of Science ®Google Scholar
• Pelosi, L. A., Voss, S., Liu, M., Gao, M., & Lemm, J. A. (2012). Effect on hepatitis C virus replication of combinations of direct-acting antivirals, including NS5A inhibitor daclatasvir. Antimicrobial Agents and Chemotherapy, 56(10), 5230–5239. doi:10.1128/AAC.01209-12
   PubMed Web of Science ®Google Scholar
• Politzer, P., & Murray, J. S. (2002). The fundamental nature and role of the electrostatic potential in atoms and molecules. Theoretical Chemistry Accounts: Theory, Computation, and Modeling (Theoretica Chimica Acta), 108(3), 134–142. doi:10.1007/s00214-002-0363-9
   Web of Science ®Google Scholar
• Politzer, P., Murray, J. S., & Peralta-Inga, Z. (2001). Molecular surface electrostatic potentials in relation to noncovalent interactions in biological systems. International Journal of Quantum Chemistry, 85(6), 676–684. doi:10.1002/qua.1706
   Web of Science ®Google Scholar
• Rajalakshmi, G., Hathwar, V. R., & Kumaradhas, P. (2014). Intermolecular interactions, charge-density distribution and the electrostatic properties of pyrazinamide anti-TB drug molecule: An experimental and theoretical charge-density study. Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials, 70(3), 568–579. doi:10.1107/S205252061303388X
   PubMedGoogle Scholar
• Rajalakshmi, G., Hathwar, V. R., & Kumaradhas, P. (2014). Topological analysis of electron density and the electrostatic properties of isoniazid: An experimental and theoretical study. Acta Crystallographica Section B Structural Science, Crystal Engineering and Materials, 70(2), 331–341. doi:10.1107/S2052520613033209
   PubMedGoogle Scholar
• Rajalakshmi, G., Pavan, M. S., & Kumaradhas, P. (2014). Charge density distribution and electrostatic interactions of ethionamide: An inhibitor of the enoyl acyl carrier protein reductase (inhA) enzyme of Mycobacterium tuberculosis. RSC Advances, 4(101), 57823–57833. doi:10.1039/C4RA07953A
   Web of Science ®Google Scholar
• Ranjith-Kumar, C. T., C., & Kao, C. (2006). Biochemical activities of the HCV NS5B RNA-dependent RNA polymerase. In S. Tan (Ed.), Hepatitis C viruses: Genomes and molecular biology (pp. 293–310). Norfolk, UK: Horizon Bioscience. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK1629/
   Google Scholar
• Rehermann, B., & Nascimbeni, M. (2005). Immunology of hepatitis B virus and hepatitis C virus infection. Nature Reviews Immunology, 5(3), 215–229. doi:10.1038/nri1573
   PubMed Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. doi:10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Rudnitskaya, A., Török, B., & Török, M. (2010). Molecular docking of enzyme inhibitors. Biochemistry and Molecular Biology Education, 38(4), 261–265. doi:10.1002/bmb.20392
   PubMed Web of Science ®Google Scholar
• Ryckaert, J., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of nalkanes. Journal of Computational Physics, 23(3), 327–341. doi:10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Schrödinger Suite, 2014-2. (2014a). Ligprep. New York, NY: Schrödinger, LLC.
   Google Scholar
• Schrodinger release.2014-2. (2014b). Maestro. New York, NY: Schrödinger, LLC.
   Google Scholar
• Schrödinger Suite. 2014-2. (2014c) Protein Preparation Wizard. NewYork, NY: Schrödinger, LLC.
   Google Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pK a prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. doi:10.1007/s10822-007-9133-z
   PubMed Web of Science ®Google Scholar
• Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006). Novel procedure for modeling ligand/receptor induced fit effects. Journal of Medicinal Chemistry, 49(2), 534–553. doi:10.1021/JM050540C
   Google Scholar
• Shih, I-h., Vliegen, I., Peng, B., Yang, H., Hebner, C., Paeshuyse, J., … Zhong, W. (2011). Mechanistic characterization of GS-9190 (tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase. Antimicrobial Agents and Chemotherapy, 55(9), 4196–4203. doi:10.1128/AAC.00307-11
   PubMed Web of Science ®Google Scholar
• Soriano, V., Vispo, E., de Mendoza, C., Labarga, P., Fernandez-Montero, J. V., Poveda, E., … Barreiro, P. (2013). Hepatitis C therapy with HCV NS5B polymerase inhibitors. Expert Opinion on Pharmacotherapy, 14(9), 1161–1170. doi:10.1517/14656566.2013.795543
   PubMed Web of Science ®Google Scholar
• Stash, A., & Tsirelson, V. (2002). WinXPRO: A program for calculating crystal and molecular properties using multipole parameters of the electron density. Journal of Applied Crystallography, 35(3), 371–373. doi:10.1107/s0021889802003230
   Web of Science ®Google Scholar
• Sun, H., Li, Y., Li, D., & Hou, T. (2013). insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches. Journal of Chemical Information and Modeling, 53(9), 2376–2389. doi:10.1021/ci400188q
   PubMed Web of Science ®Google Scholar
• Timur, S. S., Yalçın, G., Çevik, Ö., Andaç, C., & Gürsoy, R. N. (2018). Molecular dynamics, thermodynamic, and mutational binding studies for tumor-specific LyP-1 in complex with p32. Journal of Biomolecular Structure and Dynamics, 36(5), 1134–1144. doi:10.1080/07391102.2017.1313779
   PubMed Web of Science ®Google Scholar
• Wang, H., Guo, C., Chen, B.-Z., & Ji, M. (2015). Computational study on the drug resistance mechanism of HCV NS5B RNA-dependent RNA polymerase mutants V494I, V494A, M426A, and M423T to filibuvir. Antiviral Research, 113, 79–92. doi:10.1016/j.antiviral.2014.11.005
   PubMed Web of Science ®Google Scholar
• Wang, J., Wang, W., Kollman, P. A., & Case, D. A. (2006). Automatic atom type and bond type perception in molecular mechanical calculations. Journal of Molecular Graphics and Modelling, 25(2), 247–260. doi:10.1016/j.jmgm.2005.12.005
   PubMed Web of Science ®Google Scholar
• Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004). Development and testing of a general amber force field. Journal of Computational Chemistry, 25(9), 1157–1174. doi:10.1002/jcc.20035
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server), W407–W410. doi:10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Xie, Y., Alicha Ogah, C., Jiang, X., Li, J., & Shen, J. (2016). Nucleoside inhibitors of hepatitis C virus NS5B polymerase: A systematic review. Current Drug Targets, 17(13), 1560–1576. doi:10.2174/1389450117666151209123751
   PubMed Web of Science ®Google Scholar
• Xue, W., Ban, Y., Liu, H., & Yao, X. (2014). Computational study on the drug resistance mechanism against HCV NS3/4A protease inhibitors vaniprevir and MK-5172 by the combination use of molecular dynamics simulation, residue interaction network, and substrate envelope analysis. Journal of Chemical Information and Modeling, 54(2), 621–633. doi:10.1021/ci400060j
   PubMed Web of Science ®Google Scholar
• Yamamoto, T., & Miller, W. H. (2004). On the efficient path integral evaluation of thermal rate constants within the quantum instanton approximation. The Journal of Chemical Physics, 120(7), 3086–3099. doi:10.1063/1.1641005
   PubMed Web of Science ®Google Scholar
• Yan, L., Zhang, L., Zhang, Y., Qiao, X., Pan, J., Liu, H., … Yuan, H. (2018). Insight into the key features for ligand binding in Y1230 mutated c-Met kinase domain by molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 36(8), 2015–2031. doi:10.1080/07391102.2017.1340852
   PubMed Web of Science ®Google Scholar
• Yearley, E. J., Zhurova, E. A., Zhurov, V. V., & Pinkerton, A. A. (2007). Binding of genistein to the estrogen receptor based on an experimental electron density study. Journal of the American Chemical Society, 129(48), 15013–15021. doi:10.1021/ja075211j
   PubMed Web of Science ®Google Scholar
• Zhurova, E. A., Matta, C. F., Wu, N., Zhurov, V. V., & Pinkerton, AA. (2006). Experimental and theoretical electron density study of estrone. Journal of the American Chemical Society, 128(27), 8849–8861. doi:Artn Ja061080v\r Doi 10.1021/Ja061080v
   PubMed Web of Science ®Google Scholar
• Zhurova, E. A., Zhurov, V. V., Chopra, D., Stash, A. I., & Pinkerton, A. A. (2009). 17α-Estradiol·1/2 H2O: Super-structural ordering, electronic properties, chemical bonding, and biological activity in comparison with other estrogens. Journal of the American Chemical Society, 131(47), 17260–17269. doi:10.1021/ja906057z
   PubMed Web of Science ®Google Scholar
• Zhurova, E. A., Zhurov, V. V., Kumaradhas, P., Cenedese, S., & Pinkerton, A. A. (2016). Charge density and electrostatic potential study of 16α,17β-estriol and the binding of estrogen molecules to the estrogen receptors ER α and ER β. The Journal of Physical Chemistry B, 120(34), 8882–8891. doi:10.1021/acs.jpcb.6b05961
   PubMed Web of Science ®Google Scholar